ArticleBrain and behavior2025
Systemic Inflammation and Oxidative Stress Markers in Patients With Medication Overuse Headache.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Systemic Inflammation and Oxidative Stress Markers in Patients With Medication Overuse Headache.Brain and behavior · 2025Article
- Dapagliflozin Ameliorates Doxorubicin-Induced Chemobrain and Cognitive Abnormalities in Rats: Modulation of AKT/GSK-3β and Wnt/β-Catenin Pathways.Neurochemical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundRecent scientific evidence has suggested that inflammation and oxidative stress may play a significant role in the pathogenesis of medication overuse headache (MOH). This study aims to investigate the differences in peripheral markers of systemic inflammation and oxidative stress, such as the monocyte to high-density lipoprotein (HDL) ratio (MHR), and their correlation with clinical symptoms in MOH patients, episodic migraine patients, and healthy controls.
methodsThis cross-sectional study recruited MOH patients along with age- and sex-matched controls. Differences in indicators of inflammation and oxidative stress were compared across different groups, including MOH patients with different preexisting headache subtypes. Univariate and multivariate logistic regression analyses were employed to identify independent factors associated with the occurrence of MOH.
resultsThe study comprised 109 MOH patients, 68 episodic migraine patients, and 86 healthy controls. MOH patients exhibited significantly higher values of MHR, lymphocyte to HDL ratio (LHR), and neutrophil to HDL ratio (NHR) compared to healthy controls. No statistically significant differences in these indicators were observed between the MOH subgroups. Correlation analysis revealed that only the triglyceride-glucose index was negatively correlated with monthly headache days in MOH patients (r = -0.230, p = 0.016). Additionally, elevated values of MHR odds ratios ((OR) = 2.32, 95% confidence intervals (CI) 1.18-4.56), LHR (OR = 2.56, 95% CI 1.40-4.67), and NHR (OR = 2.09, 95% CI 1.16-3.75) were independently associated with MOH.
conclusionMOH patients demonstrated markedly distinct inflammatory and oxidative stress profiles. Elevated values of LHR, MHR, and NHR were independently associated with MOH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.